Delivery Order SPE2DB22D3301-SPE2DB25FX4UU
Award Date
11/1/24
Potential Completion Date
11/25/24
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,963.40, is a Firm Fixed Price Delivery Order for the supply of REVLIMID 5 MG CAPSULE 28S. The contract has an ultimate completion date of January 22, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $388,232.92, is a delivery order for 4,566,533,172 units of the drug REVLIMID 5 MG CAPSULE 100S. This is not a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $89,155.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and an ultimate completion date of March 24, 2025. The contract is for the supply of REVLIMID 15 MG CAPSULE 100S, a pharmaceutical product. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product REVLIMID 10 MG CAPSULE 28S. The contract has a ceiling value of $163,311.98 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract does not have a set-aside designation and has an ultimate completion date of July 5, 2024. Amerisourcebergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the supply of REVLIMID 10 MG Capsules. The award has a ceiling value of $105,612.88 and an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside...
This federal contract award, valued at $24,963.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of REVLIMID 2.5 MG CAPSULE 28S, a pharmaceutical product. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award valued at $178,310.12 from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of REVLIMID 10 MG CAPSULE 100S, a prescription medication. The contract is a firm fixed-price agreement with a period of performance through January 24, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for $17,497.73 to provide 4564822108 REVLIMID 25 MG CAPSULE 21S. It has a Firm Fixed Price pricing type and an ultimate completion date of June 26, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This is a $103,758.92 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of REVLIMID 5 MG CAPSULE 100S. The award has an ultimate completion date of July 14, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of REVLIMID 2.5 MG CAPSULE 28S. The contract has a ceiling value of $27,425.24 and a period of performance ending on July 28, 2025. Amerisourcebergen Drug Corp is a for-profit organization based in Conshohocken, Pennsylvania and is registered in the System for Award Management (SAM) through May 2026. This contract is...